The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world outcomes among patients with metastatic colorectal cancer treated first line with bevacizumab-awwb.
 
Ran Jin
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Adesuwa S. Ogbomo
Employment - ConcertAI
Research Funding - Amgen (Inst)
 
Neil A. Accortt
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Lincy S. Lal
Employment - ConcertAI; Optum/UnitedHealth Group
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); BMS (Inst); Daiichi Sankyo/UCB Japan (Inst); Gilead Sciences (Inst); Incyte (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Geetanjali Bishi
Employment - ConcertAI
Research Funding - Amgen (Inst)
 
Darcie Sandschafer
Employment - Amgen
Stock and Other Ownership Interests - Amgen
Expert Testimony - Amgen
 
Jerome H. Goldschmidt
Employment - Blue Ridge Cancer Care; Ontada/McKesson
Stock and Other Ownership Interests - Amgen (I)
Consulting or Advisory Role - Amgen; TG Therapeutics
Speakers' Bureau - Bristol myers squibb; G1 Therapeutics